In Partnership with: National Institutes of Health (NIH), Alzheimer’s Drug Discovery Foundation, Vanderbilt University & University of Southern California.
With funding from the National Institutes of Health (NIH), the MIND (Memory Improvement through Nicotine Dosing) Study is testing whether the use of nicotine, delivered in patch form, can safely improve memory and functioning in people who have been diagnosed with mild memory loss or mild cognitive impairment (MCI).
Some people may be hesitant to join a study involving nicotine, because the risks from smoking are well known.
However, nicotine does not cause cancer, heart disease, or respiratory illness. It’s the tar and thousands of other chemicals in cigarettes that do.
In fact, researchers have used nicotine in memory studies for more than 30 years. Nicotine, when used as prescribed by a physician, may be safe and may have medicinal benefits.
The MIND Study is by far the largest and longest-running study of its kind, testing whether nicotine can improve memory loss. No tobacco companies are involved in the design, financing, or management of the Study.